Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 30411-30412 [E8-11792]

Download as PDF Federal Register / Vol. 73, No. 102 / Tuesday, May 27, 2008 / Notices Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Jeanette M. Hosseini, PhD, Scientific Review Administrator, Office of Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–9096, jeanetteh@mail.nih.gov. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel Centers for Excellence in Research (P01). Date: June 25–27, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Gaithersburg Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878. Contact Person: Martina Schmidt, PhD, Scientific Review Administrator, Office of Scientific Review, National Center for Complementary & Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, 301–594–3456, schmidma@mail.nih.gov. Dated: May 20, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11811 Filed 5–23–08; 8:45 am] Dated: May 19, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11714 Filed 5–23–08; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meetings National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. pwalker on PROD1PC71 with NOTICES Name of Committee: National Cancer Institute Special Emphasis Panel; Mentored Clinical Scientist Research Career Development Award (K08). Date: June 25, 2008. Time: 10:30 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Robert Bird, PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8113, Bethesda, MD 20892–8328, 301–496– 7978, birdr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel Clinical Science. Date: June 23–24, 2008. Time: June 23, 2008, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. VerDate Aug<31>2005 19:50 May 23, 2008 Jkt 214001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 30411 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Digestive Diseases and Nutrition C Subcommittee. Date: June 17–18, 2008. Open: June 17, 2008, 8 a.m. to 8:30 a.m. Agenda: To review procedures and discuss policy. Place: Crowne Plaza Washington National Airport Hotel, 1480 Crystal Drive, Arlington, VA 22202. Closed: June 17, 2008, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Washington National Airport Hotel, 1480 Crystal Drive, Arlington, VA 22202. Closed: June 18, 2008, 8 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Washington National Airport Hotel, 1480 Crystal Drive, Arlington, VA 22202. Contact Person: Dan E. Matsumoto, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes Of Health, Room 749, 6707 Democracy Boulevard, Bethesda, Md 20892–5452, (301) 594–8894, matsumotod@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: May 19, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11634 Filed 5–23–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Meeting: Secretary’s Advisory Committee on Genetics, Health, and Society Pursuant to Public Law 92–463, notice is hereby given of the sixteenth meeting of the Secretary’s Advisory Committee on Genetics, Health, and Society (SACGHS), U.S. Public Health Service. The meeting will be held from 8:30 a.m. to approximately 11:30 a.m. on Monday, July 7, 2008, and 8 a.m. to approximately 5 p.m. on Tuesday, July 8, 2008, at the Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. The meeting will be open to the public with E:\FR\FM\27MYN1.SGM 27MYN1 30412 Federal Register / Vol. 73, No. 102 / Tuesday, May 27, 2008 / Notices pwalker on PROD1PC71 with NOTICES attendance limited to space available. The meeting also will be Web cast. The meeting will involve an exploration of the issues associated with the marketing of personalized genomic information and services directly to consumers. The Committee will hear presentations about these services, including the specificity of information being provided and plans for helping consumers interpret and utilize the results for healthcare decisionmaking, consumer perspectives, the state of the underlying science, and public policy considerations. As part of this exploration, the Committee will adjourn for the afternoon of July 7 to participate in a workshop sponsored by Secretary Leavitt’s Personalized Health Care Initiative on Understanding the Needs of Consumers in the Use of Genomicbased Health Information Services. The Committee also will review a proposed action plan for addressing issues associated with the genetics education and training of health professionals and move into the second stage of its priority setting process. As always, the Committee welcomes hearing from anyone wishing to provide public comment on any issue related to genetics, health and society. Individuals who would like to provide public comment should notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at 301–496–9838 or e-mail at carrs@od.nih.gov. The SACGHS office is located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Anyone planning to attend the meeting who is in need of special assistance, such as sign language interpretation or other reasonable accommodations, is also asked to contact the Executive Secretary. Under authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established SACGHS to serve as a public forum for deliberations on the broad range of human health and societal issues raised by the development and use of genetic and genomic technologies and, as warranted, to provide advice on these issues. The draft meeting agenda and other information about SACGHS, including information about access to the Web cast, will be available at the following Web site: https:// www4.od.nih.gov/oba/sacghs.htm. Dated: May 16, 2008. Jennifer Spaeth, Director, NIH Office of Federal Advisory Committee Policy. [FR Doc. E8–11792 Filed 5–23–08; 8:45 am] BILLING CODE 4140–01–P VerDate Aug<31>2005 17:22 May 23, 2008 Jkt 214001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health The National Institute of Dental and Craniofacial Research Announces Plans To Develop Its Strategic Plan for 2009–2013 and Invites Public Comments National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), Department of Health and Human Services (HHS). ACTION: Request for comments. AGENCY: SUMMARY: The NIDCR is developing a new strategic plan to guide the Institute’s research efforts over the next five years (2009–2013). NIDCR is inviting public comments and input for the development of the plan via its Web site https://www.nidcr.nih.gov, by mail or fax to the addresses below. ADDRESSES: National Institute of Dental and Craniofacial Research, Office of the Director, 31 Center Drive, Building 31 Room 2C39, MSC 2290 Bethesda, MD 20892. FAX: 301–402–2185. E-mail: https://www.nidcr.nih.gov/ NewsAndFeatures/Announcements/ StrategicPlanInput.htm. Comments should be submitted via e-mail on or before June 20, 2008. Background: NIDCR is the lead federal agency for research and research training on oral, dental and craniofacial diseases and disorders. NIDCR has a distinguished record of nearly 60 years of supporting research to advance the oral health of the nation. Achieving NIDCR’s vision of advancing the oral health and well-being for all requires having a comprehensive strategic plan that identifies the most promising opportunities for investment, delineates the Institute’s priorities, and that reflects the advice of the research community and the public at large. NIDCR achieves its mission to improve oral, dental and craniofacial health through research, research training and the dissemination of health information. DATES: Request for Comments The NIDCR seeks input to the following questions to inform the strategic plan: 1. Looking forward, should NIDCR increase its use of targeted research to ensure that key research areas with promise are addressed? If so, what priority areas would you recommend that NIDCR pursue? Targeted research is research solicited by the Institute via initiatives, RFAs or RFPs. PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 2. In your view, what are the truly ‘‘transformative’’ areas that could have the greatest benefit for advancing dental research? 3. What can be done to augment and accelerate the role and significance of dental and craniofacial research in the growing framework of translational research? 4. What should be NIDCR’s position on funding ‘‘high risk/high reward research’’? What in your view constitutes ‘‘high risk/high reward’’? 5. In realistic terms, what can—and should—NIDCR do to expand and enhance the ‘‘pipeline’’ for new dental and craniofacial researchers? 6. Please provide any additional input that you think would be useful to NIDCR in developing its 2009—2013 Strategic Plan. Individuals submitting public comments are asked to include relevant contact information [name, affiliation (if any), e-mail-address and phone]. This information may be disclosed to NIDCR senior staff serving on the strategic plan steering committee and to contractors working on behalf of NIDCR. Submission of this information is voluntary. However, the information you provide will help to categorize responses by scientific area of expertise, organizational entity or professional affiliation. Collection of this information is authorized under 42 U.S.C. 203, 241, 2891–1 and 44 U.S.C. 3101 and Sections 301 and 493 of the Public Health Service Act regarding the establishment of the National Institutes of Health, its general authority to conduct and fund research and to provide training assistance, and its general authority to maintain records in connection with its other functions. Dated: May 17, 2008. Lawrence A. Tabak, Director, National Institute of Dental and Craniofacial Research, National Institutes of Health. [FR Doc. E8–11799 Filed 5–23–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [FEMA–1755–DR] Maine; Amendment No. 1 to Notice of a Major Disaster Declaration Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 73, Number 102 (Tuesday, May 27, 2008)]
[Notices]
[Pages 30411-30412]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11792]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting: Secretary's Advisory Committee on Genetics, 
Health, and Society

    Pursuant to Public Law 92-463, notice is hereby given of the 
sixteenth meeting of the Secretary's Advisory Committee on Genetics, 
Health, and Society (SACGHS), U.S. Public Health Service. The meeting 
will be held from 8:30 a.m. to approximately 11:30 a.m. on Monday, July 
7, 2008, and 8 a.m. to approximately 5 p.m. on Tuesday, July 8, 2008, 
at the Hubert H. Humphrey Building, 200 Independence Avenue SW., 
Washington, DC 20201. The meeting will be open to the public with

[[Page 30412]]

attendance limited to space available. The meeting also will be Web 
cast.
    The meeting will involve an exploration of the issues associated 
with the marketing of personalized genomic information and services 
directly to consumers. The Committee will hear presentations about 
these services, including the specificity of information being provided 
and plans for helping consumers interpret and utilize the results for 
healthcare decisionmaking, consumer perspectives, the state of the 
underlying science, and public policy considerations. As part of this 
exploration, the Committee will adjourn for the afternoon of July 7 to 
participate in a workshop sponsored by Secretary Leavitt's Personalized 
Health Care Initiative on Understanding the Needs of Consumers in the 
Use of Genomic-based Health Information Services. The Committee also 
will review a proposed action plan for addressing issues associated 
with the genetics education and training of health professionals and 
move into the second stage of its priority setting process.
    As always, the Committee welcomes hearing from anyone wishing to 
provide public comment on any issue related to genetics, health and 
society. Individuals who would like to provide public comment should 
notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at 
301-496-9838 or e-mail at carrs@od.nih.gov. The SACGHS office is 
located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Anyone 
planning to attend the meeting who is in need of special assistance, 
such as sign language interpretation or other reasonable 
accommodations, is also asked to contact the Executive Secretary.
    Under authority of 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established SACGHS to serve as a public forum for deliberations on the 
broad range of human health and societal issues raised by the 
development and use of genetic and genomic technologies and, as 
warranted, to provide advice on these issues. The draft meeting agenda 
and other information about SACGHS, including information about access 
to the Web cast, will be available at the following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.

    Dated: May 16, 2008.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory Committee Policy.
 [FR Doc. E8-11792 Filed 5-23-08; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.